دورية أكاديمية
أعرض في EDS

Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases.

التفاصيل البيبلوغرافية
العنوان: Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases.
المؤلفون: Nicholson SA; Samantha A Nicholson, Buhle Moyo, Patrick B Arbuthnot, Wits/SA MRC Antiviral Gene Therapy Research Unit, School of Pathology, Health Sciences Faculty, University of the Witwatersrand, Wits 2050, Johannesburg, South Africa., Moyo B; Samantha A Nicholson, Buhle Moyo, Patrick B Arbuthnot, Wits/SA MRC Antiviral Gene Therapy Research Unit, School of Pathology, Health Sciences Faculty, University of the Witwatersrand, Wits 2050, Johannesburg, South Africa., Arbuthnot PB; Samantha A Nicholson, Buhle Moyo, Patrick B Arbuthnot, Wits/SA MRC Antiviral Gene Therapy Research Unit, School of Pathology, Health Sciences Faculty, University of the Witwatersrand, Wits 2050, Johannesburg, South Africa.
المصدر: World journal of hepatology [World J Hepatol] 2015 Apr 28; Vol. 7 (6), pp. 859-73.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101532469 Publication Model: Print Cited Medium: Print ISSN: 1948-5182 (Print) NLM ISO Abbreviation: World J Hepatol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
Original Publication: Beijing, China : Baishideng
مستخلص: Liver diseases are one of the leading causes of mortality in the world. The hepatic illnesses, which include inherited metabolic disorders, hemophilias and viral hepatitides, are complex and currently difficult to treat. The maturation of gene therapy has heralded new avenues for developing effective intervention for these diseases. DNA modification using gene therapy is now possible and available technology may be exploited to achieve long term therapeutic benefit. The ability to edit DNA sequences specifically is of paramount importance to advance gene therapy for application to liver diseases. Recent development of technologies that allow for this has resulted in rapid advancement of gene therapy to treat several chronic illnesses. Improvements in application of derivatives of zinc finger proteins (ZFPs), transcription activator-like effectors (TALEs), homing endonucleases (HEs) and clustered regularly interspaced palindromic repeats (CRISPR) and CRISPR associated (Cas) systems have been particularly important. These sequence-specific technologies may be used to modify genes permanently and also to alter gene transcription for therapeutic purposes. This review describes progress in development of ZFPs, TALEs, HEs and CRISPR/Cas for application to treating liver diseases.
References: Nature. 2011 Oct 12;478(7369):391-4. (PMID: 21993621)
EMBO Mol Med. 2014 May 23;6(6):835-48. (PMID: 24859981)
Pediatrics. 1952 Aug;10(2):169-80. (PMID: 12983120)
J Bacteriol. 2008 Feb;190(4):1390-400. (PMID: 18065545)
Blood. 2014 Jan 16;123(3):317-25. (PMID: 24227821)
Cell. 2013 Dec 19;155(7):1479-91. (PMID: 24360272)
Mol Ther Nucleic Acids. 2014 Aug 19;3:e186. (PMID: 25137139)
Nat Protoc. 2009;4(10):1471-501. (PMID: 19798082)
Nature. 2005 Jun 2;435(7042):646-51. (PMID: 15806097)
N Engl J Med. 2014 Mar 6;370(10):901-10. (PMID: 24597865)
Cell Mol Life Sci. 2014 Jul;71(14):2641-9. (PMID: 24509823)
Trends Biotechnol. 2013 Jul;31(7):397-405. (PMID: 23664777)
Nucleic Acids Res. 2011 Nov;39(21):9283-93. (PMID: 21813459)
Proc Natl Acad Sci U S A. 1977 Oct;74(10):4641-5. (PMID: 270706)
Nature. 2011 Mar 31;471(7340):602-7. (PMID: 21455174)
Hum Gene Ther. 2013 Mar;24(3):245-58. (PMID: 23360514)
Nat Methods. 2012 Oct;9(10):973-5. (PMID: 22941364)
Nucleic Acids Res. 2011 May;39(10):4330-9. (PMID: 21288879)
Nucleic Acids Res. 2001 Sep 15;29(18):3882-91. (PMID: 11557821)
Genome Res. 2012 Mar;22(3):539-48. (PMID: 22183967)
Gene Ther. 2004 Oct;11 Suppl 1:S10-7. (PMID: 15454952)
Annu Rev Pharmacol Toxicol. 2000;40:581-616. (PMID: 10836148)
Nature. 1988 Oct 6;335(6190):563-4. (PMID: 3047590)
Plant Physiol. 2009 Aug;150(4):1677-86. (PMID: 19458115)
Genome Res. 2013 Sep;23 (9):1422-33. (PMID: 23788652)
Liver Int. 2015 Mar;35(3):805-15. (PMID: 24620920)
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10570-5. (PMID: 9724744)
Nucleic Acids Res. 2010 Aug;38(15):e152. (PMID: 20530528)
Am J Hum Genet. 1976 Sep;28(5):482-8. (PMID: 984044)
Mob DNA. 2014 Mar 03;5(1):7. (PMID: 24589358)
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1495-500. (PMID: 10660690)
Mol Ther. 2014 Feb;22(2):303-11. (PMID: 24025750)
Curr Opin Mol Ther. 2007 Oct;9(5):423-31. (PMID: 17932806)
J Biol Chem. 2012 Nov 9;287(46):38427-32. (PMID: 23019344)
Med Clin North Am. 2014 Jan;98(1):39-54. (PMID: 24266913)
Cell Stem Cell. 2014 Jul 3;15(1):31-6. (PMID: 24996168)
N Engl J Med. 2013 May 2;368(18):1685-94. (PMID: 23534542)
J Virol. 1988 Aug;62(8):2836-44. (PMID: 2839705)
Genome Res. 2014 Jan;24(1):132-41. (PMID: 24253446)
Biochem Pharmacol. 1996 Jan 26;51(2):173-82. (PMID: 8615886)
Gene. 1993 Mar 15;125(1):1-10. (PMID: 8166773)
Hum Gene Ther. 2014 Sep;25(9):844-55. (PMID: 25072305)
Nat Biotechnol. 2013 Mar;31(3):251-8. (PMID: 23417094)
Thromb Res. 1982 Mar 1;25(5):415-22. (PMID: 7071812)
Biochemistry. 2003 Feb 25;42(7):2137-48. (PMID: 12590603)
PLoS One. 2014 Jan 20;9(1):e85755. (PMID: 24465685)
Nat Biotechnol. 2014 Jun;32(6):551-3. (PMID: 24681508)
Nat Rev Genet. 2010 Sep;11(9):636-46. (PMID: 20717154)
Nat Methods. 2012 Jul 01;9(8):805-7. (PMID: 22751204)
Nat Methods. 2013 Apr;10(4):329-31. (PMID: 23435258)
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):E2579-86. (PMID: 22949671)
Mol Ther. 2011 Apr;19(4):694-702. (PMID: 21224832)
Nat Biotechnol. 2008 Jul;26(7):808-16. (PMID: 18587387)
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10757-61. (PMID: 7479878)
J Invest Dermatol. 2014 May;134(5):1246-54. (PMID: 24317394)
Nucleic Acids Res. 2011 Jul;39(13):5790-9. (PMID: 21421566)
J Biol Chem. 2011 Sep 9;286(36):31896-903. (PMID: 21775431)
Nat Biotechnol. 2008 Jun;26(6):702-8. (PMID: 18500334)
Nucleic Acids Res. 2013 Oct;41(19):e180. (PMID: 23945944)
Mol Ther. 2005 Oct;12(4):610-7. (PMID: 16039907)
Nucleic Acids Res. 2012 Oct;40(19):9887-96. (PMID: 22879377)
Nat Methods. 2013 Mar;10(3):243-5. (PMID: 23396285)
Genome Res. 2013 Mar;23(3):530-8. (PMID: 23222846)
Haemophilia. 2004 Sep;10(5):483-90. (PMID: 15357775)
Annu Rev Genomics Hum Genet. 2013;14:135-58. (PMID: 23701416)
J Mol Biol. 2000 Jan 28;295(4):719-27. (PMID: 10656784)
Nucleic Acids Res. 2011 Nov;39(21):9275-82. (PMID: 21813460)
Mol Ther Nucleic Acids. 2014 Feb 04;3:e146. (PMID: 24496438)
Hepatology. 2013 Jun;57(6):2458-68. (PMID: 23325555)
Cell Stem Cell. 2013 Feb 7;12(2):238-51. (PMID: 23246482)
F1000Prime Rep. 2013 Nov 01;5:47. (PMID: 24273648)
Sci Rep. 2013;3:2510. (PMID: 23974631)
Mol Ther. 2013 Oct;21(10):1889-97. (PMID: 23883864)
RNA Biol. 2012 Sep;9(9):1134-8. (PMID: 22954644)
Nat Biotechnol. 2002 Feb;20(2):135-41. (PMID: 11821858)
Nat Methods. 2011 Jul 17;8(9):753-5. (PMID: 21765410)
Nature. 2011 Jun 26;475(7355):217-21. (PMID: 21706032)
Mol Ther. 2010 May;18(5):947-54. (PMID: 20160705)
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20526-31. (PMID: 19910532)
N Engl J Med. 2011 Jun 23;364(25):2429-38. (PMID: 21696309)
J Virol. 2008 Aug;82(16):8013-21. (PMID: 18524822)
Nat Methods. 2008 May;5(5):374-5. (PMID: 18446154)
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4509-13. (PMID: 8183939)
Mol Ther. 2008 Jun;16(6):1105-12. (PMID: 18431360)
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14628-33. (PMID: 9843940)
Cell. 1980 May;20(1):185-97. (PMID: 6156002)
Science. 2009 Dec 11;326(5959):1509-12. (PMID: 19933107)
Adv Med Sci. 2007;52:29-36. (PMID: 18217387)
Annu Rev Phytopathol. 2010;48:419-36. (PMID: 19400638)
Nat Rev Microbiol. 2011 Jun;9(6):467-77. (PMID: 21552286)
Mol Cell. 2008 Jul 25;31(2):294-301. (PMID: 18657511)
Nucleic Acids Res. 2013 Mar 1;41(5):e63. (PMID: 23275534)
J Mol Biol. 2006 Aug 25;361(4):744-54. (PMID: 16872628)
Science. 2013 Feb 15;339(6121):819-23. (PMID: 23287718)
Nat Biotechnol. 2011 Feb;29(2):149-53. (PMID: 21248753)
Med Oncol. 2014 Aug;31(8):95. (PMID: 24990099)
Nat Biotechnol. 2013 Sep;31(9):822-6. (PMID: 23792628)
Hepatology. 2006 Sep;44(3):521-6. (PMID: 16941687)
Biochem Soc Trans. 2001 May;29(Pt 2):196-201. (PMID: 11356153)
Mol Plant Microbe Interact. 2000 Dec;13(12 ):1322-9. (PMID: 11106024)
Nature. 2014 Mar 6;507(7490):62-7. (PMID: 24476820)
Nat Biotechnol. 2013 Jan;31(1):23-4. (PMID: 23302927)
Cell. 2013 Jul 18;154(2):442-51. (PMID: 23849981)
Science. 1999 Dec 17;286(5448):2244-5. (PMID: 10636774)
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6064-8. (PMID: 8016116)
Cell Stem Cell. 2014 Jul 3;15(1):12-3. (PMID: 24996165)
Nucleic Acids Res. 2013 Apr;41(7):4118-28. (PMID: 23408851)
Mol Biosyst. 2012 Apr;8(4):1255-63. (PMID: 22301904)
Genome Res. 2010 Jan;20(1):81-9. (PMID: 19952142)
J Mol Biol. 2006 Jan 20;355(3):443-58. (PMID: 16310802)
Nucleic Acids Res. 2001 Sep 15;29(18):3757-74. (PMID: 11557808)
Nucleic Acids Res. 2013 Oct;41(19):e181. (PMID: 23945932)
Pharmaceuticals (Basel). 2012 Dec 10;5(12):1372-92. (PMID: 24281341)
Curr Opin Microbiol. 2011 Feb;14(1):47-53. (PMID: 21215685)
Nat Genet. 1994 Apr;6(4):335-41. (PMID: 8054972)
Nucleic Acids Res. 2013 Nov;41(20):e190. (PMID: 24003033)
J Biomol Screen. 2013 Apr;18(4):378-87. (PMID: 23042077)
Nat Methods. 2011 Aug 07;8(9):765-70. (PMID: 21822273)
فهرسة مساهمة: Keywords: Clustered regularly interspaced short palindromic repeats; Gene therapy; Homing endonucleases; Liver diseases; Transcription activator-like effectors; Zinc fingers
تواريخ الأحداث: Date Created: 20150505 Date Completed: 20150504 Latest Revision: 20201001
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC4411528
DOI: 10.4254/wjh.v7.i6.859
PMID: 25937863
قاعدة البيانات: MEDLINE
الوصف
تدمد:1948-5182
DOI:10.4254/wjh.v7.i6.859